Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Immunotherapy biomarkers

Original research

Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers

Online download statistics by month:

Online download statistics by month: December 2021 to March 2024

	Abstract	Full	Pdf
Dec 2021	1296	1308	637
Jan 2022	794	817	256
Feb 2022	261	265	121
Mar 2022	225	230	117
Apr 2022	365	383	168
May 2022	306	327	185
Jun 2022	325	341	153
Jul 2022	224	234	110
Aug 2022	274	275	115
Sep 2022	365	372	130
Oct 2022	450	456	142
Nov 2022	258	262	138
Dec 2022	132	132	87
Jan 2023	168	175	78
Feb 2023	205	212	134
Mar 2023	236	239	136
Apr 2023	118	120	94
May 2023	214	216	80
Jun 2023	141	147	83
Jul 2023	159	163	87
Aug 2023	298	299	60
Sep 2023	133	135	53
Oct 2023	161	164	74
Nov 2023	282	284	101
Dec 2023	367	371	192
Jan 2024	225	225	240
Feb 2024	265	267	123
Mar 2024	267	269	173
Total	8514	8688	4067